To think of uplisting to a major exchange is in my opinion a valid reason to execute a rs. The merging company is established with marketed products and it is wise to be in a major exchange like Nasdaq or Amex to gain more exposure to institutional investors.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On January 26, 2021, holders of 85.8% of the voting power of our capital stock acted by written consent in lieu of a meeting to approve an amendment to the Company’s Certificate of Incorporation, as amended, effecting a one-for-173 reverse split of the Company’s common stock and to change our corporate name from Boston Therapeutics, Inc. to “Nanomix Holdings, Inc.” The name change and reverse stock split are subject to approval by FINRA.
News 
Market Data 
Discover 
